These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5030806)

  • 21. Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.
    Valeriote F; Vietti T; Coulter D
    J Natl Cancer Inst; 1980 Apr; 64(4):801-5. PubMed ID: 6928994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transplantability, development and methotrexate sensitivity of mouse leukemia L1210 resistant to olivomycin].
    Prokhorova EV
    Antibiotiki; 1978 Jun; 23(6):553-7. PubMed ID: 677843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of the L1210 antileukemic activity of O-2,2'-cyclocytidine, monoacetate (anhydro-ara-C; NSC-129220)--comparison with cytosine arabinoside (NSC-63878) with respect to treatment schedule dependency.
    Venditti JM; Baratta MC; Greenberg NH; Abbott BJ; Kline I
    Cancer Chemother Rep; 1972 Aug; 56(4):483-92. PubMed ID: 5081591
    [No Abstract]   [Full Text] [Related]  

  • 24. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia.
    Chello PL; Sirotnak FM; Dorick DM; Moccio DM
    Cancer Treat Rep; 1979; 63(11-12):1889-94. PubMed ID: 526921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
    Osswald H; Herrmann R; Youssef M
    Cancer Lett; 1985 Dec; 29(3):277-82. PubMed ID: 4075296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous and amethopterin-induced death of L1210 leukaemia cells in vivo.
    Hofer KG; Rosenoff S; Prensky W; Hughes WL
    Nature; 1969 Feb; 221(5180):576-7. PubMed ID: 5789315
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. VII.
    Venditti JM; Sheldon DR; Goldin A
    Cancer Res; 1964 Jan; 24(1 Pt 1):145-210. PubMed ID: 5878215
    [No Abstract]   [Full Text] [Related]  

  • 28. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.
    Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
    Cancer Res; 1976 Dec; 36(12):4672-8. PubMed ID: 1000510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The return of antimetabolite sensitivity in methotrexate- and 6-mercaptopurine-resistant L1210 murine leukemia by the process of adaptive selection.
    Wallerstein H; Slater LM; Eng B; Calman N
    Cancer Res; 1972 Oct; 32(10):2235-40. PubMed ID: 5080766
    [No Abstract]   [Full Text] [Related]  

  • 30. Potentiation of the antitumor activity of methotrexate by concurrent infusion of thymidine.
    Semon JH; Grindey GB
    Cancer Res; 1978 Sep; 38(9):2905-11. PubMed ID: 679199
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of solid L1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate.
    Weinstein JN; Magin RL; Cysyk RL; Zaharko DS
    Cancer Res; 1980 May; 40(5):1388-95. PubMed ID: 6892792
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of priming dose schedules in methotrexate treatment of mouse leukemia L1210.
    Straus MJ; Mantel N; Goldin A
    Cancer Res; 1971 Oct; 31(10):1429-33. PubMed ID: 5095131
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chemotherapy of L1210 leukemia: comparison of 7 drugs given either continuously for 20 days, or in a single massive dose, early or late].
    Mathé G; Schwarzenberg L; Hayat M; Schneider M
    Rev Fr Etud Clin Biol; 1968 Dec; 13(10):951-60. PubMed ID: 5306738
    [No Abstract]   [Full Text] [Related]  

  • 34. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiosensitivity of drug-resistant L1210 leukemia.
    Johnson RE
    Cancer Res; 1967 Feb; 27(2):251-4. PubMed ID: 6018559
    [No Abstract]   [Full Text] [Related]  

  • 36. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells.
    Roberts D; Peck C; Hilliard S; Wingo W
    Cancer Res; 1979 Oct; 39(10):4048-54. PubMed ID: 476642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of methotrexate on the leukemic cell cycle in mouse ascitic leukemia L1210].
    Goncharova SA; Frankfurt OS
    Tsitologiia; 1975 Sep; 17(9):1051-6. PubMed ID: 1166521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved methotrexate therapy of murine tumors obtained by probenecid-mediated pharmacological modulation at the level of membrane transport.
    Sirotnak FM; Moccio DM; Hancock CH; Young CW
    Cancer Res; 1981 Oct; 41(10):3944-9. PubMed ID: 7285003
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of 5,8-dideazaisopteroylglutamate (IAHQ) on L1210 leukemia in mice when given alone and in combination with methotrexate, probenecid, or verapamil.
    Hynes JB; Smith AB; Gale GR
    Cancer Chemother Pharmacol; 1986; 18(3):231-4. PubMed ID: 3802378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.